Detalhe da pesquisa
1.
Prognostic impact of histological discordance between transurethral resection and radical cystectomy.
BJU Int
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344879
2.
The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy.
Jpn J Clin Oncol
; 54(2): 192-200, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974430
3.
Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
Int J Clin Oncol
; 29(2): 205-212, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112832
4.
Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
Int J Urol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687165
5.
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
Int J Urol
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695571
6.
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
Int J Urol
; 31(5): 526-533, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240169
7.
Robot-assisted radical nephrectomy using novel surgical robot platform, hinotori: Report of initial series of 13 cases.
Int J Urol
; 30(12): 1175-1179, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37654155
8.
Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy.
Int J Urol
; 30(1): 57-61, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513615
9.
Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan.
Int J Urol
; 30(9): 772-777, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345413
10.
Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
Int J Urol
; 30(12): 1112-1119, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605814
11.
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.
Int J Urol
; 30(5): 473-481, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788781
12.
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
Int J Urol
; 30(9): 730-736, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575640
13.
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
BJU Int
; 130(2): 226-234, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110696
14.
Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Jpn J Clin Oncol
; 52(8): 944-949, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462401
15.
Limited impact of erectile function on health-related quality of life in Japanese men undergoing robot-assisted radical prostatectomy.
Int J Urol
; 29(9): 956-961, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176812
16.
Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.
Int J Urol
; 29(10): 1195-1203, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858755
17.
Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Int J Urol
; 29(7): 632-638, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293022
18.
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab.
Cancer Sci
; 112(2): 760-773, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33283385
19.
Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.
BMC Cancer
; 21(1): 266, 2021 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706705
20.
Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents.
Int J Clin Oncol
; 26(9): 1745-1751, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34255227